Resmed Inc

US

RMD

Health Care

180.35 ₽

Current price

Hold
180.35 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    263 / 663

  • Position in country

    5820 / 14179

  • Return on Assets, %

    13.1

    -11.9

  • Net income margin, %

    17.9

    -12.5

  • EBITDA margin, %

    33

    -2.5

  • Debt to Equity, %

    27.3

    15

  • Intangible assets and goodwill, %

    49

    3.9

  • Revenue CAGR 3Y, %

    12.6

    12.6

  • Total Equity change 1Y, %

    19.8

    0

  • Revenue Y, % chg

    19.6

    4.6

  • P/E

    30.7

    28.3

  • P/BV

    6

    1.7

  • P/S

    6

    3.7

  • EV/S

    6.2

    3.2

  • EV/EBITDA

    20.3

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    10.8

    66.5

  • Forward P/E

    23.1

    19.2

  • Dividend Yield, %

    1

    1.8

  • Forward Dividend Yield, %

    1.1

    0.2

  • Expected dividend per share

    2

    0

  • Payout Ratio, %

    30.3

    17.3

  • Dividend Ex Date

    2024-02-07

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Resmed Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    27337.9

  • Ticker

    RMD.N

  • ISIN

    US7611521078

  • IPO date

    1995-06-01

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-01-25

  • Date fact. publication of reports

    2023-12-31

Company Description

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.